Isomorphic Labs Announces $2.1B Funding to Scale its AI Drug Design Engine
Insider Brief PRESS RELEASE — Isomorphic Labs, an AI-first drug design and development company, has announced it has raised $2.1 Billion in Series B funding. This latest round of investment will accelerate the company’s evolution from pioneering novel AI models to applying them at scale. The financing round is led by Thrive Capital, and includes participation from […]